[ET Net News Agency, 12 November 2024] UBS raised the target price for InnoCare (09969)
to HKD9.8 from HKD8.6 and maintained the "buy" rating.
The research house said based on the Q324 result, it raises 2024-26E revenue
(+7.3%/2.7%2.1%) and GM (+0.3/0.5/0.0ppt) estimates, and lowers the expense ratio
estimates, leading to the narrowed 2024-26E net loss. (rc)